Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-115146
Filing Date
2024-10-16
Accepted
2024-10-16 20:39:38
Documents
1
Period of Report
2024-10-11

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 11955
  Complete submission text file 0000950170-24-115146.txt   13437
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 781-999-0232
Q32 Bio Inc. (Issuer) CIK: 0001661998 (see all company filings)

EIN.: 473468154 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address Q32 BIO INC. 830 WINTER STREET WALTHAM MA 02451
Business Address
Violette Shelia M. (Reporting) CIK: 0002016144 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38433 | Film No.: 241375726